Neuroepithelial neoplasms displaying neuronal features

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 1695 times

37

Neuroepithelial neoplasms displaying neuronal features

Neoplastic cells with morphologic and/or immunohistochemical characteristics of neurons may occur in neuroepithelial neoplasms as:

Neuroblast-like cells are present in embryonal neoplasms such as primitive neuroectodermal tumors (PNETs), and are admixed with ganglion cells in ganglioneuroblastomas, which are classified with embryonal neoplasms (see Chapter 38). Ganglion cells and/or neurocytes, but not neuroblasts, form a significant component of neoplasms grouped as neuronal and mixed neuronal-glial tumors in the WHO classification (2007):

With the exception of very rare anaplastic variants, tumors in this category display an indolent behavior, unlike biologically aggressive embryonal tumors.

GANGLIOCYTOMA AND GANGLIOGLIOMA

These tumors contain well-differentiated ganglion cells, either alone (gangliocytoma) or with a neoplastic glial component (ganglioglioma). Rarely, the glial component of a ganglioglioma progresses to an anaplastic form (anaplastic ganglioglioma). However, gangliogliomas containing a diffusely infiltrating astrocytic component do not undergo anaplastic progression with the same frequency as diffuse astrocytomas.

MICROSCOPIC APPEARANCES

Cursorily, neoplastic ‘ganglion’ cells look like large neurons, possessing a round nucleus, prominent nucleolus, and Nissl substance, but many have obvious cytologic atypia on closer inspection. Their distribution is characteristically disorganized. Ganglion cell neoplasms exhibit a range of histologic appearances; ganglion cells may either dominate the picture or be part of a polymorphous population of cells.

Gangliocytomas consist of disorganized ganglion cells set against a neuropil-like background or a lacy, fibrillary background containing a few reactive astrocytes (Fig. 37.2). Groups of ganglion cells may appear in nests enclosed by thin fibrovascular septa. In some cases, extensive desmoplasia may surround elongated cells that have a neuronal immunophenotype. Neoplastic ganglion cells possess abnormal, thickened processes and some have double nuclei. Small round cells with a relatively high nuclear:cytoplasmic ratio, but without nuclear hyperchromasia, represent a further neuronal phenotype encountered in these neoplasms (Fig. 37.2).

Gangliogliomas also contain neoplastic glial cells, which may greatly outnumber the ganglion cells. Neoplastic glia in gangliogliomas may have an obvious astrocytic morphology, but some ganglion cell neoplasms contain cells of an indeterminate nature (Figs 37.3, 37.4). While the glial component of some gangliogliomas appears as a fibrillary astrocytoma, other gangliogliomas manifest as a pilocytic astrocytoma or pleomorphic xanthoastrocytoma with a ganglion cell component. Eosinophilic granular bodies and neovascularization, of the type seen in pilocytic astrocytomas, may be evident. Degenerative cytologic changes take the form of nuclear pleomorphism and hyperchromasia, in the absence of mitoses. Some gangliogliomas are focally desmoplastic, or may spread into the subarachnoid space, provoking desmoplasia.

Ganglion cell neoplasms may contain aggregates of lymphoid cells, many of which are perivascular. Finding a mitotic figure in a ganglion cell neoplasm is unusual. If mitoses accompany cytologic pleomorphism in the glial element of a ganglioglioma, the possibility of its anaplastic transformation should be considered. However, this event occurs in less than 5% of gangliogliomas, and it is important to recall that invasion of gray matter by an anaplastic astrocytoma enters the differential diagnosis of these histopathologic features.

Ganglion cells are immunoreactive for NEU-N, synaptophysin, and neurofilament proteins (Fig. 37.4). Electron microscopy reveals dense-core synaptic vesicles.

Small round undifferentiated cells with a high nuclear:cytoplasmic ratio and nuclear hyperchromasia are combined with ganglion cells in the ganglioneuroblastoma, which is regarded as a variant of PNET (Fig. 37.5). Mitoses and apoptotic bodies are usually identifiable among the small cells. Recognition of the embryonal element is important because its presence confers a much poorer prognosis and has implications for therapy. The combination of neoplastic neuronal and glial cells that are both undifferentiated and differentiated (i.e. ganglioneuroblastoma/glioblastoma, or malignant glioma/PNET) is recognized as an entity, but extremely rare. Like the ganglioneuroblastoma, these neoplasms should probably be regarded as variants of PNET.

image DIFFERENTIAL DIAGNOSIS OF GANGLION CELL NEOPLASMS

Diagnostic difficulty sometimes surrounds the separation of ganglion cell neoplasms from gliomas that diffusely invade gray matter or from other neuroepithelial neoplasms that contain ganglion cells or large non-neuronal cells with prominent nucleoli. In making a diagnosis, consider the following:

image Are neoplastic ganglion cells present? Disorganized neoplastic ganglion cells do not show the uniform orientation and orderly arrangement of neurons in the cerebral cortex, may be identified away from gray matter in the deep white matter or subarachnoid space (though a few scattered neurons are normally found in the subcortical white matter – especially of the temporal lobe), and have abnormal cytologic characteristics, including double nuclei.

image Are proliferating neuroblasts combined with neoplastic ganglion cells? Consider a diagnosis of ganglioneuroblastoma, which is a variant of PNET.

image Are ganglion cells present in a parenchymal neoplasm with the architectural and cytological features of a neurocytoma? If so, it may be an example of the rare extraventricular neurocytoma.

image Not all cells with large nuclei and prominent nucleoli are ganglion cells. Similar cells are found in giant cell glioblastoma, pleomorphic xanthoastrocytoma, and the subependymal giant cell astrocytoma of tuberous sclerosis. Check the immunophenotype of the cells. Ganglion cells are immunoreactive for NEU-N, synaptophysin, and neurofilament proteins, but not for glial fibrillary acidic protein (GFAP).

image Mitoses are exceptional in gangliogliomas. The presence of scattered mitoses in limited biopsy material indicates either infiltration of gray matter by an anaplastic astrocytoma or rare anaplastic transformation of a ganglioglioma. In either event, the prognosis is much worse than that of a ganglioglioma or an astrocytoma.

DESMOPLASTIC INFANTILE GANGLIOGLIOMA (DIGG)

The DIGG is a supratentorial neuroepithelial neoplasm of infancy with a good prognosis (WHO grade I). It is closely related to the desmoplastic infantile astrocytoma (DIA), which has a similar clinical presentation and an identical histopathology, except that it lacks ganglion cells. Both DIGG and DIA are large superficial cerebral neoplasms, which are associated with cysts.

MACROSCOPIC APPEARANCES

The desmoplastic nature of a DIGG gives it a firm texture. Part of the neoplasm may lie in the subarachnoid space and be attached to the dura. Cysts are usually evident, and a single cyst may occupy a large volume.

MICROSCOPIC APPEARANCES

In areas of prominent desmoplasia, neoplastic glial cells are spindle-shaped with elongated hyperchromatic nuclei (Fig. 37.6). In some areas, the fascicular architecture and desmoplasia give way to foci of plump astrocytic cells or even limited numbers of poorly differentiated neuroepithelial cells. Ganglion cells with large nuclei are found within DIGGs (Fig. 37.6), but not DIAs, and can be numerous, mimicking a ganglioglioma. A small number of mitoses with a normal configuration may be present among the poorly differentiated cells.

Immunohistochemistry shows that many cells express GFAP. Synaptophysin and neurofilament antibodies label ganglion cells and some cells without obvious neuronal morphology. Ultrastructural examination reveals that many of the astrocytic cells have a prominent basal lamina.

CENTRAL AND EXTRAVENTRICULAR NEUROCYTOMA

The central neurocytoma is a distinctive intraventicular neoplasm usually located in the region of the septum pellucidum/foramen of Monro (Fig. 37.7). Since the neuronal nature of its isomorphous cells was demonstrated, it has become the archetypal neurocytic neoplasm, despite its idiosyncratic clinicopathologic features. Rare circumscribed intraparenchymal tumors with a similar phenotype have been reported to occur throughout the neuraxis, and the term extraventricular neurocytoma has been coined for these. The cerebellar liponeurocytoma (below) also belongs to this category.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The central neurocytoma is a soft, well-circumscribed neoplasm that often contains flecks of calcification. It consists of monotonous round to oval cells, which have fibrillary cytoplasm and round nuclei with finely granular chromatin (Fig. 37.8). A fixation artifact giving a ‘fried egg’ appearance to the cells is sometimes seen. The sheet of neoplastic cells is divided by anuclear fibrillary zones, which contain fine capillaries. Mitotic figures are seldom seen. Rarely, ganglion cells are present, evincing the neuronal lineage of the neoplasm.

Reports of a few central neurocytomas with a relatively high Ki-67 immunolabeling index or foci of vascular proliferation and necrosis have introduced the concept of ‘atypical’ neurocytomas, but several years of recurrence-free survival are possible even if a tumor shows these features.

Immunohistochemistry reveals synaptophysin in the cell bodies/ fibrillary matrix. GFAP antibodies label reactive astrocytes and a few neoplastic cells in about 10% of tumors. Neurofilament protein is demonstrable in the occasional ganglion cell. Ultrastructurally, the cells contain microtubules and a few dense-core secretory vesicles.

CEREBELLAR LIPONEUROCYTOMA

This very rare neoplasm occurs in the cerebellum of young and middle-aged adults. Historically, it has been referred to as a lipidized medulloblastoma, but its biologic behavior is not that of a PNET. In fact, this is an indolent neoplasm, which has a good prognosis following surgery alone.

PAPILLARY GLIONEURONAL TUMOR

The papillary glioneuronal tumor (PGNT) is a rare, usually cerebral, neoplasm that presents at any age. While it is regarded as WHO grade I, occasional examples appear to behave aggressively.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

PGNTs can be solid or cystic and often show focal calcification. At the microscopic level, there is a pseudo-papillary architecture characterized by discohesive elements centered on hyalinized blood vessels. Small, poorly differentiated, GFAP-immunopositive cells with round nuclei and a high nuclear:cytoplasmic ratio have a perivascular distribution, but give way to interpapillary groups of cells with a (mainly neurocytic) neuronal morphology and immunophenotype. Mitoses are rare, and necrosis and microvascular proliferation are not features of the neoplastic process (Fig. 37.10).

ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE

The rosette-forming glioneuronal tumor (RGNT) is a rare WHO grade I tumor of the fourth ventricle/cerebellar vermis. An early synonym was dysembryoplastic neuroepithelial tumor of the cerebellum.

PARAGANGLIOMA OF THE FILUM TERMINALE

This neoplasm shares the pathologic features of other extra-adrenal paragangliomas. It generally occurs in adults, and usually presents with sciatica. Significant pressor amine secretion has not been reported.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Paraganglioma of the filum terminale is an encapsulated neoplasm arising from the filum terminale or lumbosacral roots and forming a lozenge-shaped structure. It appears richly vascular and may be cystic.

Microscopically, nests of oval or polyhedral cells with granular cytoplasm are surrounded by a delicate fibrovascular network (Fig. 37.12). Some cytologic pleomorphism may be apparent, but is of no biologic significance. Nuclei contain stippled chromatin. Ganglion cells may make up a large proportion of the cells (gangliocytic paraganglioma).

Immunoreactivity for synaptophysin and chromogranin is present, and ultrastructural examination reveals dense-core granules. Sustentacular cells at the periphery of the cell nests are immunoreactive for S-100 protein.

DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR (DNT)

The DNT occurs predominantly in the cerebrum, particularly in the temporal lobe. It has characteristic clinical and radiologic features, which can help to secure a diagnosis when histologic assessment is difficult. With typical examples, surgery is effective in alleviating epilepsy, and recurrence of subtotally resected DNTs is exceptional.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

DNTs usually display a distinctive multinodular architecture. They may occupy a small or a large area of cerebral cortex, and involved gyri are often protuberant. Involvement of subcortical white matter is unusual and not extensive.

DNTs are currently divided into two forms: simple and complex (Figs 37.13, 37.14). Both have the characteristic ‘specific glioneuronal element’, which has a nodular architecture and contains masses of oligodendrocyte-like cells (OLCs). The OLCs are set against a mucinous matrix, in which microcyst formation occurs. Focally, the OLCs have a columnar arrangement and seem to be suspended from neuritic processes or capillaries. Small cysts sometimes contain a mature neuron, which appears suspended (sometime described as ‘floating’) in a mucopolysaccharide-rich medium. The complex form also includes groups of glial cells, often with a nodular architecture. In isolation, the glial cells have the features of an astrocytoma, oligodendroglioma, or mixed glioma. Focal calcification is seen in some DNTs.

The surrounding cortex, which may show discrete areas of dysplasia, is diffusely invaded by OLCs, but perineuronal satellitosis is not a prominent feature. Dystrophic calcification may be seen, but mitoses are rare.

Immunohistochemistry and ultrastructural examination reveal that few OLCs have a neuronal or astrocytic phenotype, though they have been regarded as neuroepithelial cells capable of divergent differentiation on the basis of these analyses. The larger cells in the glioneuronal element are immunoreactive for neuronal markers, such as synaptophysin and neurofilament proteins. Glial cells are usually immunoreactive for GFAP. The growth fraction, as assessed with Ki-67 antibodies, is usually below 1%, but not zero.

DYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM

The dysplastic gangliocytoma of the cerebellum (Lhermitte–Duclos disease) is generally regarded as a hamartoma, rather than a neoplasm. Its growth is thought to be related to hypertrophy rather than replication of the constituent cells. However, regrowth after excision has been reported.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

The folia within a dysplastic gangliocytoma of the cerebellum appear abnormally thickened (Fig. 37.15a). Enlarged abnormal neurons replace internal granule cells, distorting the normal cerebellar architecture (Fig. 37.15b). The cells are immunoreactive for synaptophysin and neurofilament proteins and their axons in the molecular layer are often myelinated. There is a loss of Purkinje cells and rarefaction or cavitation of white matter in the core of affected folia.

HYPOTHALAMIC NEURONAL HAMARTOMA

This non-neoplastic lesion is evident as a small mass ventral to the hypothalamus, and is composed of ganglion cells arranged in clusters against a neuropil-like background (Fig. 37.16). Generally, the hamartoma is asymptomatic, but it occasionally produces epilepsy (sometimes gelastic seizures) or endocrine syndromes, such as precocious puberty, which result from the capacity of the ganglion cells to secrete hormones in an aberrant fashion.

REFERENCES

Ganglion cell tumors

Blümcke, I., Löbach, M., Wolf, H.K., et al. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors. Microsc Res Tech.. 1999;46:53–58.

Campos, M.G., Zentner, J., Ostertun, B., et al. Anaplastic ganglioglioma: case report and review of the literature. Neurol Res.. 1994;16:317–320.

Celli, P., Scarpinati, M., Nardacci, B., et al. Gangliogliomas of the cerebral hemispheres. Report of 14 cases with long-term follow-up and review of the literature. Acta Neurochir (Wien). 1993;125:52–57.

Dash, R.C., Provenzale, J.M., McComb, R.D., et al. Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature. Arch Pathol Lab Med.. 1999;123:342–345.

Felix, I., Bilbao, J.M., Asa, S.L., et al. Cerebral and cerebellar gangliocytomas: a morphological study of nine cases. Acta Neuropathol (Berl).. 1994;88:246–251.

Forshew, T., Tatevossian, R.G., Lawson, A.R., et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol.. 2009;218:172–181.

Haddad, S.F., Moore, S.A., Menezes, A.H., et al. Ganglioglioma: 13 years of experience. Neurosurgery.. 1992;31:171–178.

Hakim, R., Loeffler, J.S., Anthony, D.C., et al. Gangliogliomas in adults. Cancer.. 1997;79:127–131.

Jay, V., Squire, J., Becker, L.E., et al. Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis. Cancer.. 1994;73:2862–2868.

Johannsson, J.H., Rekate, H.L., Roessmann, U. Gangliogliomas: pathological and clinical correlation. J Neurosurg.. 1981;54:58–63.

Kleinschmidt-DeMasters, B.K., Birks, D.K., Aisner, D.L., et al. Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization. Am J Surg Pathol.. 2011;35:1894–1901.

Kordek, R., Biernat, W., Sapieja, W., et al. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study. Acta Neuropathol (Berl).. 1995;89:194–197.

Luyken, C., Blümcke, I., Fimmers, R., et al. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer.. 2004;101:146–155.

Schindler, G., Capper, D., Meyer, J., et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol (Berl).. 2011;121:397–405.

Wolf, H.K., Müller, M.B., Spänle, M., et al. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol (Berl).. 1994;88:166–173.

Zentner, J., Wolf, H.K., Ostertun, B., et al. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry.. 1994;57:1497–1502.

Neurocytoma

Ellison, D.W., Zygmunt, S.C., Weller, R.O. Neurocytoma/lipoma (neurolipocytoma) of the cerebellum. Neuropathol Appl Neurobiol.. 1993;19:95–98.

Figarella-Branger, D., Pellissier, J.F., Daumas-Duport, C., et al. Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol.. 1992;16:97–109.

Hessler, R.B., Lopes, M.B., Frankfurter, A., et al. Cytoskeletal immunohistochemistry of central neurocytomas. Am J Surg Pathol.. 1992;16:1031–1038.

Jackson, T.R., Regine, W.F., Wilson, D., et al. Cerebellar liponeurocytoma. Case report and review of the literature. J Neurosurg. 2001;95:700–703.

Jouvet, A., Lellouch-Tubiana, A., Boddaert, N., et al. Fourth ventricle neurocytoma with lipomatous and ependymal differentiation. Acta Neuropathol (Berl).. 2005;109:346–351.

Mrak, R.E., Yasargil, M.G., Mohapatra, G., et al. Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. Hum Pathol.. 2004;35:1156–1159.

Söylemezoglu, F., Scheithauer, B.W., Esteve, J., et al. Atypical central neurocytoma. J Neuropathol Exp Neurol.. 1997;56:551–556.

von Deimling, A., Janzer, R., Kleihues, P., et al. Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol (Berl). 1990;79:473–479.

Desmoplastic tumors

Craver, R.D., Nadell, J., Nelson, J.S., et al. Desmoplastic infantile ganglioglioma. Pediatr Dev Pathol.. 1999;2:582–587.

De Munnynck, K., Van Gool, S., Van Calenbergh, F., et al. Desmoplastic infantile ganglioglioma: a potentially malignant tumor? Am J Surg Pathol.. 2002;26:1515–1522.

Komori, T., Scheithauer, B.W., Parisi, J.E., et al. Mixed conventional and desmoplastic infantile ganglioglioma: an autopsied case with 6-year follow-up. Mod Pathol.. 2001;14:720–726.

Louis, D.N., von Deimling, A., Dickersin, G.R., et al. Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic study. Hum Pathol.. 1992;23:1402–1409.

Ng, T.H., Fung, C.F., Ma, L.T. The pathological spectrum of desmoplastic infantile gangliogliomas. Histopathology.. 1990;16:235–241.

Paulus, W., Schlote, W., Perentes, E., et al. Desmoplastic supratentorial neuroepithelial tumours of infancy. Histopathology.. 1992;21:43–49.

VandenBerg, S.R., May, E.E., Rubinstein, L.J., et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (desmoplastic infantile gangliogliomas). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg. 1987;66:58–71.

Dysembryoplastic neuroepithelial tumors

Baisden, B.L., Brat, D.J., Melhem, E.R., et al. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: a lesion often misdiagnosed as glioma: report of 10 cases. Am J Surg Pathol.. 2001;25:494–499.

Daumas-Duport, C., Scheithauer, B.W., Chodkiewicz, J.P., et al. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery.. 1988;23:545–556.

Hirose, T., Scheithauer, B.W. Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol (Berl).. 1998;95:649–654.

Hirose, T., Scheithauer, B.W., Lopes, M.B., et al. Dysembryoplastic neuroepithelial tumor (DNT): an immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol.. 1994;53:184–195.

Honavar, M., Janota, I., Polkey, C.E. Histological heterogeneity of dysembryoplastic neuroepithelial tumour: identification and differential diagnosis in a series of 74 cases. Histopathology.. 1999;34:342–356.

Raymond, A.A., Halpin, S.F., Alsanjari, N., et al. Dysembryoplastic neuroepithelial tumor. Features in 16 patients. Brain. 1994;117:461–475.

Other glioneuronal tumors

Barbashina, V., Salazar, P., Ladanyi, M., et al. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis. Am J Surg Pathol.. 2007;31:1196–1202.

Coons, S.W., Rekate, H.L., Prenger, E.C., et al. The histopathology of hypothalamic hamartomas: study of 57 cases. J Neuropathol Exp Neurol.. 2007;66:131–141.

Edgar, M.A., Rosenblum, M.K. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med.. 2007;131:228–233.

Kamalian, N., Abbassioun, K., Amirjamshidi, A., et al. Paraganglioma of the filum terminale internum. Report of a case and review of the literature. J Neurol.. 1987;235:56–59.

Kim, D.H., Suh, Y.L. Pseudopapillary neurocytoma of temporal lobe with glial differentiation. Acta Neuropathol (Berl).. 1997;94:187–191.

Komori, T., Scheithauer, B.W., Anthony, D.C., et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol.. 1998;22:1171–1183.

McLendon, R.E., Bentley, R.C., Parisi, J.E., et al. Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literature. Arch Pathol Lab Med.. 1997;121:485–492.

Prayson, R.A. Papillary glioneuronal tumor. Arch Pathol Lab Med.. 2000;124:1820–1823.

Teo, J.G., Gultekin, S.H., Bilsky, M., et al. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including rosetted) islands: report of 4 cases. Am J Surg Pathol.. 1999;23:502–510.

Wolf, H.K., Campos, M.G., Zentner, J., et al. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol.. 1993;52:499–506.